|
V.V. Tsukanov, A.V. Vasyutin, Yu.L. Tonkikh, O.S. Amelchugova
THERAPY OF NONALCOHOLIC FATTY LIVER DISEASE. IS THERE A PLACE FOR HEPATOPROTECTORS?
|
№18 / 2014
|
|
V.B. Grinevich, E.I. Sas, Yu.A. Kravchuk, O.I. Efimov
AASLD GUIDLINES FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE. POTENTIALS FOR THE USE IN RUSSIA
|
№2 / 2014
|
|
V.V. Tsukanov, O.S. Amelchugova, A.V. Vasyutin, Yu.L.Tonkikh
PATIENT WITH NAFLD: ALGORITHM FOR DIAGNOSIS AND TREATMENT
|
№18 / 2013
|
|
S. M. Alekhin, M. N. Somova
NONALCOHOLIC FATTY LIVER DISEASE: NEW POTENTIALS FOR THE COMBINED THERAPY
|
№10 / 2013
|
|
A.S.Ametov
Type 2 Diabetes Mellitus And Non-alcoholic Fatty Liver Disease: Guidelines For Endocrinologists
|
№5 / 2013
|
|
L.A. Zvenigorodskaya
Lipid-lowering Therapy In Patients With Nonalcoholic Fatty Liver Disease
|
№10 / 2011
|
|
N.V. Loseva, Ye.Ye. Moiseyenko
Experience Of Use Of Drug Dibicor In The Complex Therapy Of Non-alcoholic Fatty Liver Disease
|
№15 / 2010
|
|
O.M. Drapkina, O.N. Korneev
Nonalcoholic Fatty Liver Disease And Cardiovascular Risk: Influence Of Female Sex
|
№15 / 2010
|
|
O. Drapkina, D. Tutnov
Optimization Of Antihypertensive Therapy In Patients With Non-alcoholic Fatty Liver Disease
|
№10 / 2010
|
|
G.M. Bartashevich
Clinical Experience Of Berlitione Use In Liver Diseases
|
№6 / 2009
|
Русский
